Vicente Trivino Castillo Jr., M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1716 N 27th St, Nederland, TX 77627 Phone: 409-721-5234 Fax: 409-722-4016 |
Ryan C Mchugh, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2400 Highway 365 Ste 208, Nederland, TX 77627 Phone: 409-724-7904 Fax: 409-226-3374 |
News Archive
Models based on this approach could help doctors make better treatment choices for individual patients, who often respond differently to the same drug, and could help drug developers identify the ideal compounds on which to focus their research.
A team of orthopaedic researchers has found definitive, genetic proof of how the most common form of arthritis destroys joint cartilage in nearly 21 million aging Americans, according to a study published online Sept. 2 in the Journal of Bone and Mineral Research. The findings serve as an important foundation for the design of new treatments for osteoarthritis (OA), researchers said.
The immunosuppressive drug fingolimod (trade name: Gilenya-) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) assessed whether fingolimod offers an added benefit compared with the present standard therapy.
CryoCor, Inc. has announced that the United States Patent and Trademark Office (USPTO) has declared a patent interference between a patent application exclusively licensed by CryoCor and two patents held by CryoCath Technologies Inc.
The most commonly used gene expression profile test used to help predict breast cancer recurrence may not be as cost-effective as once thought, say a team of researchers led by Georgetown Lombardi Comprehensive Cancer Center.
› Verified 7 days ago